🇺🇸 FDA
Patent

US 11898207

Methods of isolating neoantigen-specific T cell receptor sequences

granted A61KA61K40/11A61K40/32

Quick answer

US patent 11898207 (Methods of isolating neoantigen-specific T cell receptor sequences) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K40/11, A61K40/32, A61K40/42, A61K40/4201